(Q43593047)

25 November 2017

title

Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndrome (English)

1 reference

25 November 2017

Leong L Ng

9

0 references

author name string

Onkar S Dhillon

1

1 reference

25 November 2017

Sohail Q Khan

2

1 reference

25 November 2017

Hafid K Narayan

3

1 reference

25 November 2017

Kelvin H Ng

4

1 reference

25 November 2017

Noor Mohammed

5

1 reference

25 November 2017

Paulene A Quinn

6

1 reference

25 November 2017

Iain B Squire

7

1 reference

25 November 2017

Joan E Davies

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

9 November 2009

1 reference

25 November 2017

1 reference

25 November 2017

volume

118

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

249-257

1 reference

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Atherosclerosis and proteinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Do metalloproteinases destabilize vulnerable atherosclerotic plaques?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Elevation of plasma matrix metalloproteinase-9 in the culprit coronary artery in patients with acute myocardial infarction: clinical evidence from distal protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Universal definition of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Predictors of hospital mortality in the global registry of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20090226

21 January 2018

Identifiers

DOI

10.1042/CS20090226

1 reference

25 November 2017

1 reference